Suppr超能文献

以环糊精为络合剂的伊曲康唑口服溶液制备方法的影响

Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents.

作者信息

Holvoet C, Vander Heyden Y, Plaizier-Vercammen J

机构信息

Department of Analytical Chemistry and Pharmaceutical Technology, Vrije Universiteit Brussel-VUB, Brussels, Belgium.

出版信息

Pharmazie. 2007 Jul;62(7):510-4.

Abstract

In the literature, solubility values of itraconazole complexed with 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) were found which were still much too low to obtain the target concentration of 1 g itraconazole/100 ml, the concentration of the marketed itraconazole formulation Sporanox (Janssen Pharmaceutica). Therefore, we compared two preparation methods: the classical and the dissolving method to investigate if the method of preparation can have an influence on the solubility of itraconazole complexed with cyclodextrin (CD). With the classical method, the active compound and the CDs are jointly dissolved with a co-solvent, propylene glycol, in water. With the dissolving method, the active compound is first dissolved separately in a solvent in which it dissolves well, while the CDs are dissolved in water, before mixing. Three different CDs were used and compared for their complexing capacity with itraconazole. The complex formation of itraconazole with HP-beta-CD, sulfobutylether-7-beta-cyclodextrin (SBE-7-beta-CD) and maltosyl-beta-cyclodextrin (malt-beta-CD) was investigated at pH 2, in the presence of 10% propylene glycol for an oral solution. These three CDs were chosen as they can also serve in formulations for parenteral use. The method of preparation had an important influence on the complex formation. With the dissolving method, a much higher solubility of itraconazole was obtained using the same CD concentration than with the classical method. Inclusion capacity obtained with the dissolving method was comparable for HP-beta-CD and SBE-7-beta-CD: 1 g itraconazole/100 ml of 25% HP-beta-CD or of 30% SBE-7-beta-CD. In 100 ml of 40% malt-beta-CD only about 500 mg of itraconazole could be dissolved. With the classical method only around 160 mg itraconazole could be dissolved with 100 ml 40 % HP-beta-CD or SBE-7-beta-CD. Due to the fast preparation, once the CD amount is known by pretests, the dissolving method shows also an advantage for industrial production.

摘要

在文献中,已发现伊曲康唑与2-羟丙基-β-环糊精(HP-β-CD)形成的复合物的溶解度值仍远低于获得1 g伊曲康唑/100 ml目标浓度(市售伊曲康唑制剂斯皮仁诺(杨森制药公司)的浓度)。因此,我们比较了两种制备方法:经典方法和溶解方法,以研究制备方法是否会对伊曲康唑与环糊精(CD)形成的复合物的溶解度产生影响。采用经典方法时,活性化合物和环糊精与助溶剂丙二醇一起在水中溶解。采用溶解方法时,活性化合物首先分别溶解在其能良好溶解的溶剂中,而环糊精则先溶解在水中,然后再混合。使用了三种不同的环糊精,并比较了它们与伊曲康唑的络合能力。在pH值为2、存在10%丙二醇的条件下,研究了伊曲康唑与HP-β-CD、磺丁基醚-7-β-环糊精(SBE-7-β-CD)和麦芽糊精-β-环糊精(麦芽-β-CD)形成复合物的情况,用于口服溶液。选择这三种环糊精是因为它们也可用于肠胃外给药制剂。制备方法对复合物的形成有重要影响。采用溶解方法时,在相同的环糊精浓度下,伊曲康唑的溶解度比经典方法高得多。采用溶解方法时,HP-β-CD和SBE-7-β-CD的包合能力相当:1 g伊曲康唑/100 ml的25% HP-β-CD或30% SBE-7-β-CD。在100 ml的40%麦芽-β-CD中,只能溶解约500 mg的伊曲康唑。采用经典方法时,100 ml 40%的HP-β-CD或SBE-7-β-CD只能溶解约160 mg伊曲康唑。由于制备速度快,一旦通过预试验确定了环糊精的用量,溶解方法在工业生产中也显示出优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验